Isoflavones Derived from Soy Beans Prevent MuRF1-Mediated Muscle Atrophy in C2C12 Myotubes through SIRT1 Activation
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Proinflammatory cytokines are factors that induce ubiquitin-proteasome-dependent proteolysis in skeletal muscle, causing muscle atrophy. Although isoflavones, as potent antioxidative nutrients, have been known to reduce muscle damage during the catabolic state, the non-antioxidant effects of isoflavones against muscle atrophy are not well known. Here we report on the inhibitory effects of isoflavones such as genistein and daidzein on muscle atrophy caused by tumor necrosis factor (TNF)-α treatment. In C2C12 myotubes, TNF-α treatment markedly elevated the expression of the muscle-specific ubiquitin ligase MuRF1, but not of atrogin-1, leading to myotube atrophy. We found that MuRF1 promoter activity was mediated by acetylation of p65, a subunit of NFκB, a downstream target of the TNF-α signaling pathway; increased MuRF1 promoter activity was abolished by SIRT1, which is associated with deacetylation of p65. Of interest, isoflavones induced expression of SIRT1 mRNA and phosphorylation of AMP kinase, which is well known to stimulate SIRT1 expression, although there was no direct effect on SIRT1 activation. Moreover, isoflavones significantly suppressed MuRF1 promoter activity and myotube atrophy induced by TNF-α in C2C12 myotubes. These results suggest that isoflavones suppress myotube atrophy in skeletal muscle cells through activation of SIRT1 signaling. Thus, the efficacy of isoflavones could provide a novel therapeutic approach against inflammation-related muscle atrophy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S. H., & Goldberg, A. L. (2004) · Cell · doi:10.1016/s0092-8674(04)00400-3 · Cited by 3,012
IKKβ/NF-κB Activation Causes Severe Muscle Wasting in Mice
Cai, D., Frantz, J. D., Tawa, N. E., Melendez, P. A., Oh, B.-C., Lidov, H. G. W., Hasselgren, P.-O., Frontera, W. R., Lee, J., Glass, D. J., et al. (2004) · Cell · doi:10.1016/j.cell.2004.09.027 · Cited by 1,367
Mechanism of Human SIRT1 Activation by Resveratrol
Borra, M. T., Smith, B. C., & Denu, J. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501250200 · Cited by 1,065
The Molecular Basis of Skeletal Muscle Atrophy
Jackman, R. W., & Kandarian, S. C. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00579.2003 · Cited by 1,008
SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1
Pacholec, M., Bleasdale, J. E., Chrunyk, B., Cunningham, D., Flynn, D., Garofalo, R. S., Griffith, D., Griffor, M., Loulakis, P., Pabst, B., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.088682 · Cited by 915
Resveratrol is not a direct activator of SIRT1 enzyme activity
Beher, D., Wu, J., Cumine, S., Kim, K. W., Lu, S., Atangan, L., & Wang, M. (2009) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2009.00901.x · Cited by 426
Posttranslational modifications control FoxO3 activity during denervation
Bertaggia, E., Coletto, L., & Sandri, M. (2012) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00142.2011 · Cited by 114
Hirasaka, K., Kohno, S., Goto, J., Furochi, H., Mawatari, K., Harada, N., Hosaka, T., Nakaya, Y., Ishidoh, K., Obata, T., et al. (2007) · Diabetes · doi:10.2337/db06-1768 · Cited by 69
Self-citation
Cited by
Liu, H.-W., & Chang, S.-J. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00636 · Cited by 113
Kim, C., & Hwang, J.-K. (2020) · Nutrients · doi:10.3390/nu12041079 · Cited by 80
“In terms of protein turnover related pathway, pro-inflammatory cytokines not only inactivate PI3K-Akt pathway [10,11] but also upregulate muscle ring-finger protein-1 (MuRF1), a major regulator of ubiquitin proteasome system for proteolysis [21].”
BackgroundPomiès, P., Blaquière, M., Maury, J., Mercier, J., Gouzi, F., & Hayot, M. (2016) · PLOS ONE · doi:10.1371/journal.pone.0160092 · Cited by 70
“reverse C2C12 muscle cell atrophy caused by TNF-α through the inhibition of MurF1 expression [23,24], while resveratrol treatment of dexamethasone-atrophied L6 myotubes prevented muscle atrophy in association with repression of atrogin-1 and MuRF1 expression [25].”
BackgroundFlavones Inhibit LPS-Induced Atrogin-1/MAFbx Expression in Mouse C2C12 Skeletal Myotubes
SHIOTA, C., ABE, T., KAWAI, N., OHNO, A., TESHIMA-KONDO, S., MORI, H., TERAO, J., TANAKA, E., & NIKAWA, T. (2015) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.61.188 · Cited by 46
Flavonoids: Nutraceutical Potential for Counteracting Muscle Atrophy
Kim, C., & Hwang, J.-K. (2020) · Food Science and Biotechnology · doi:10.1007/s10068-020-00816-5 · Cited by 45
Metadata
- Authors
- HIRASAKA, K., MAEDA, T., IKEDA, C., HARUNA, M., KOHNO, S., ABE, T., OCHI, A., MUKAI, R., OARADA, M., ESHIMA-KONDO, S., OHNO, A., OKUMURA, Y., TERAO, J., & NIKAWA, T.
- Venue
- Journal of Nutritional Science and Vitaminology
- Published
- 2013
- Volume
- 59
- Issue
- 4
- Pages
- 317-324
- ISSN
- 0301-4800 (ISSN-L)
- 1881-7742
- OpenAlex
- W1967568088
- Cited by
- 59
- References
- 8
- FWCI
- 1.08
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.